about
The impact of a community trial on the pharmacological treatment in the individuals with the metabolic syndrome: findings from the Isfahan Healthy Heart Program, 2001-2007.Association between Salt Intake and Albuminuria in Normotensive and Hypertensive IndividualsDeterminants of tobacco use among youths in Isfahan, Iran.Cumulative prevalence of risk factors for atherosclerotic cardiovascular diseases in Iranian adolescents: IHHP-HHPC.Dietary sodium and potassium intake and their association with blood pressure in a non-hypertensive Iranian adult population: Isfahan salt study.Metabolic Syndrome and the Risk of Ischemic Stroke.A Cost-Benefit and Accurate Method for Assessing Microalbuminuria: Single versus Frequent Urine Analysis.Carotenoids as Potential Antioxidant Agents in Stroke Prevention: A Systematic Review.Obesity and cardiometabolic risk factors in a representative population of Iranian adolescents and adults in comparison to a Western population: the Isfahan Healthy Heart Programme.Gender differences in risk factors and outcomes after cardiac rehabilitation.Changes in lipid profile of patients referred to a cardiac rehabilitation program.Successful Retrieval of embolized atrial septal defect occluder and patent foramen ovale closure device using novel coronary wire trap technique.Potato consumption and cardiovascular disease risk factors among Iranian population.Relationship between C-reactive protein and atherosclerotic risk factors and oxidative stress markers among young persons 10-18 years old.Short-term results of a community-based program on promoting healthy lifestyle for prevention and control of chronic diseases in a developing country setting: Isfahan Healthy Heart Program.Stroke in Isfahan, Iran: hospital admission and 28-day case fatality ratePrevalence, awareness, treatment, control, and risk factors of hypertension among adults: a cross-sectional study in Iran
P50
Q36524834-2A4E984B-180C-4D7A-BB47-089F002FE74EQ37221899-C5407457-FD34-48E4-8E91-ACF368F95430Q38552274-820BEBCF-4776-4168-BAC3-9C60D0A62F90Q39740897-FE04194A-22E4-4E6E-9DAF-498CB27F9B8AQ40113447-22A092B2-4E92-4017-88C5-7CD16903CC59Q40524930-CFFE307B-5129-4E55-972D-BB00032CE1B8Q41861563-4BEDF70D-74AB-41FB-94B1-74C95F048E43Q42285316-E3E3E90B-9AAA-41DD-A940-5E0A23C596E1Q43298240-11B70825-118F-4F40-B64E-95E1433EB0B8Q46154803-2ED710AF-4DD4-4891-B7BE-79202DF6FF29Q46447895-26739E3F-D41B-4278-85DB-D7072F4121A0Q48028200-E55AB114-D7DE-41A0-B32C-89592F5F5F56Q51356385-C672BB09-A4F0-4AE2-AD7F-062E4306D2BDQ51479828-E35BE7C1-6272-4BA3-9B49-DD368555393FQ51805068-E0EBDD27-EEA3-4845-94E5-2CF1F6233D29Q81523955-45AB907E-78A5-40E0-A212-ABE780085C49Q88883290-BBB4AEB8-6CE0-4BD6-8748-01F3D1D269D5
P50
description
researcher ORCID ID = 0000-0003-0736-2090
@en
wetenschapper
@nl
name
Alireza Khosravi
@ast
Alireza Khosravi
@en
Alireza Khosravi
@es
Alireza Khosravi
@nl
type
label
Alireza Khosravi
@ast
Alireza Khosravi
@en
Alireza Khosravi
@es
Alireza Khosravi
@nl
prefLabel
Alireza Khosravi
@ast
Alireza Khosravi
@en
Alireza Khosravi
@es
Alireza Khosravi
@nl
P1153
37110827700
P31
P496
0000-0003-0736-2090